25 results
Thumbnail

D2.19 - Can Drug Provocation Be Avoided in Low-Risk Quinolone Reactions?

Thumbnail

D2.17 - Diagnostic profitability of penicilloyl-polylysine and minor determinant mixture in urgent/preferred beta-lactam allergy studies in hospitalized patients from january 2023 to december 2025

Thumbnail

D2.20 - Selective Fixed Drug Eruption from Etoricoxib with Safe Celecoxib Use: Role of Patch Testing

Thumbnail

D2.21 - The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity

Thumbnail

D2.29 - Use and knowledge of Phadiatop Infant and Fx5 in children from a primary care healthcare area

Thumbnail

D2.63 - Airborne allergic contact dermatitis in a textile worker: role of formaldehyde and methylisothiazolinones

Thumbnail

D2.64 - Occupational allergic contact dermatitis due to rubber additives: clinical features and occupational implications

Thumbnail

D2.72 - Radiological heterogeneity and inflammatory phenotypes in allergic bronchopulmonary aspergillosis

Thumbnail

D2.58 - Nickel Sensitization and Reversible Airway Dysfunction: Evidence from Pulmonary Function Response to Nickel Avoidance

Thumbnail

D2.59 - Refining Quality of Life Assessment in CSU: Validation and Threshold Determination of the CU-Q2oL questionnaire

Thumbnail

D2.61 - Allergic Contact Dermatitis Due to Disperse Textile Dyes: A 10-Year Review

Thumbnail

D2.62 - Atypical Chronic Cheilitis as Manifestation of Atopic Dermatitis: A Diagnostic Dilemma

Thumbnail

D2.65 - Allergic cheilitis related to vaginal lubricant: a case report

Thumbnail

D2.66 - Allergic contact dermatitis to cobalt and concomitant sensitization to nickel and chromium

Thumbnail

D2.67 - Clinical Profile of Allergic Contact Dermatitis in Workers and Factors Associated with Occupational Outcomes

Thumbnail

D2.217 - Structured Follow-Up Intervals Enhance Adherence to Sublingual Immunotherapy in Patients with Allergic Rhinitis: Real-World Evidence from a Stepwise Approach

Thumbnail

D2.218 - Effectiveness of the 300IR house dust mite sublingual tablet according to the patients’ sensitisation and allergy profile in the real-world, non-interventional VORAN study

Thumbnail

D2.222 - A real-world observational study following the first year of SQ grass or SQ tree SLIT-tablet treatment to evaluate persistence and adherence in routine clinical practice among general practitioners in Norway

Thumbnail

D2.226 - Evaluation of the Immunogenicity and Stability of an Aluminum-Adsorbed Allergen Immunotherapy Using Specific IgG Titration in a Murine Model

Thumbnail

D2.228 - Effectiveness and Safety of Subcutaneous Immunotherapy for Patients Allergic to Either Cat Dander or Dermatophagoides/Cat Dander: Real World Data